Roshan Colah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roshan Colah has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Dipika Mohanty
Indian Council of Medical Research
17 shared publications - Malay B. Mukherjee
Department of Haematogenetics, National Institute of Immunohaematology (ICMR), KEM Hospital Campus, Parel, Mumbai, India
10 shared publications K Ghosh
8 shared publicationsK. Ghosh
National Institute of Immunohaematology (ICMR), Mumbai, India
4 shared publicationsA Gorakshakar
Indian Council of Medical Research
3 shared publicationsA. C. Gorakshakar
HLA Department, Institute of Immunohaematology (ICMR) , 13th Floor, NMS Bldg, K.E.M.Hospital, Parel, Mumbai 400 012, Maharashtra, India
3 shared publications
Latest Publications
- 25 June 2013
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 36 (1) , e15-e17
Hemoglobin variants in Muslim community in South Gujarat, Western India
- 25 June 2013
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 36 (1) , e15-e17
Hemoglobin variants in Muslim community in South Gujarat, Western India
- 1 April 2008
- Vol. 127 (4) , 366-9
Iron deficiency anaemia in sickle cell disorders in India.
Iron deficiency anaemia (IDA) is uncommon in individuals with sickle cell disease (SCD) because of availability of an adequate iron source potentially from increased red cell turnover and from blood transfusions. Also, iron deficiency anaemia can often go unnoticed because the sickle cell disease patients are already anaemic. Iron deficiency in sickle cell patients may result in lowering the intracellular haemoglobin concentration and this may ameliorate sickling. The present study was undertaken to determine the prevalence of iron deficiency anaemia and the response of iron supplementation in sickle cell disorders in tribal population of the four States viz. Maharashtra, Gujarat, Orissa and Tamil Nadu. A total of 8434 individuals (7105 AA, 1267 AS and 62 SS) were tested for zinc protoporphyrin/haem (ZPP/H) ratio and haemoglobin levels. Twenty two sickle cell anaemia (SS), 47 sickle cell trait (AS) and 150 normal control (AA) individuals who were iron deficient, were given iron therapy for a period of 12 wk and the laboratory investigations were repeated at the 13th wk. Sixty seven per cent of subjects with sickle cell anaemia and 26 per cent with sickle cell trait had elevated ZPP/H ratios (>80 micromol/mol) as against 22.8 per cent of normal individuals. The elevated ZPP/H ratios is an indicator of microcytic anaemia of iron deficiency. Following iron therapy, an improvement in the Hb levels and ZPP/H ratios was observed in both sickle cell disorders and normal individual cases. This study suggests that iron deficiency anaemia is an important problem in Indian sickle cell anaemia patients and iron supplementation should be given only in proven cases of iron deficiency anaemia.
- 1 April 2008
- Vol. 127 (4) , 366-9
Iron deficiency anaemia in sickle cell disorders in India.
Iron deficiency anaemia (IDA) is uncommon in individuals with sickle cell disease (SCD) because of availability of an adequate iron source potentially from increased red cell turnover and from blood transfusions. Also, iron deficiency anaemia can often go unnoticed because the sickle cell disease patients are already anaemic. Iron deficiency in sickle cell patients may result in lowering the intracellular haemoglobin concentration and this may ameliorate sickling. The present study was undertaken to determine the prevalence of iron deficiency anaemia and the response of iron supplementation in sickle cell disorders in tribal population of the four States viz. Maharashtra, Gujarat, Orissa and Tamil Nadu. A total of 8434 individuals (7105 AA, 1267 AS and 62 SS) were tested for zinc protoporphyrin/haem (ZPP/H) ratio and haemoglobin levels. Twenty two sickle cell anaemia (SS), 47 sickle cell trait (AS) and 150 normal control (AA) individuals who were iron deficient, were given iron therapy for a period of 12 wk and the laboratory investigations were repeated at the 13th wk. Sixty seven per cent of subjects with sickle cell anaemia and 26 per cent with sickle cell trait had elevated ZPP/H ratios (>80 micromol/mol) as against 22.8 per cent of normal individuals. The elevated ZPP/H ratios is an indicator of microcytic anaemia of iron deficiency. Following iron therapy, an improvement in the Hb levels and ZPP/H ratios was observed in both sickle cell disorders and normal individual cases. This study suggests that iron deficiency anaemia is an important problem in Indian sickle cell anaemia patients and iron supplementation should be given only in proven cases of iron deficiency anaemia.
- 30 June 2007
- Vol. 6 (2) , 470-5
First-trimester prenatal diagnosis of pyruvate kinase deficiency in an Indian family with the pyruvate kinase-Amish mutation.
Pyruvate kinase (PK) deficiency is a rare red cell glycolytic enzymopathy. The purpose of the present investigation was to offer prenatal diagnosis for PK deficiency to a couple who had a previous child with severe enzyme deficiency and congenital non-spherocytic hemolytic anemia. PK deficiency was identified in the family by assaying the enzyme activity in red cells. Chorionic villus sampling was performed in an 11-week gestation and the mutation was located in exon 10 of the PKLR gene characterized by polymerase chain reaction and using restriction endonuclease digestion with the MspI enzyme, which was confirmed by DNA sequencing on the ABI 310 DNA sequencer. Both the parents were heterozygous for the 1436G-->A [479 Arg-->His] mutation in exon 10 and the proband was homozygous for this mutation. The fetus was also heterozygous for this mutation and the pregnancy was continued. Prenatal diagnosis allowed the parents with a severely affected child with PK deficiency to have the reproductive choice of having the fetus tested in a subsequent pregnancy.
- 30 June 2007
- Vol. 6 (2) , 470-5
First-trimester prenatal diagnosis of pyruvate kinase deficiency in an Indian family with the pyruvate kinase-Amish mutation.
Pyruvate kinase (PK) deficiency is a rare red cell glycolytic enzymopathy. The purpose of the present investigation was to offer prenatal diagnosis for PK deficiency to a couple who had a previous child with severe enzyme deficiency and congenital non-spherocytic hemolytic anemia. PK deficiency was identified in the family by assaying the enzyme activity in red cells. Chorionic villus sampling was performed in an 11-week gestation and the mutation was located in exon 10 of the PKLR gene characterized by polymerase chain reaction and using restriction endonuclease digestion with the MspI enzyme, which was confirmed by DNA sequencing on the ABI 310 DNA sequencer. Both the parents were heterozygous for the 1436G-->A [479 Arg-->His] mutation in exon 10 and the proband was homozygous for this mutation. The fetus was also heterozygous for this mutation and the pregnancy was continued. Prenatal diagnosis allowed the parents with a severely affected child with PK deficiency to have the reproductive choice of having the fetus tested in a subsequent pregnancy.
- 21 December 2006
- Published by Wiley in British Journal of Haematology
- Vol. 136 (3) , 512-513
G6PD Namoru (208 T→ C) is the major polymorphic variant in the tribal populations in southern India
- 21 December 2006
- Published by Wiley in British Journal of Haematology
- Vol. 136 (3) , 512-513
G6PD Namoru (208 T→ C) is the major polymorphic variant in the tribal populations in southern India
- 20 May 2005
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (5) , 345-349
Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling
- 20 May 2005
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (5) , 345-349
Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling
- Open Access
- 1 January 2005
- Published by CLOCKSS Archive in Indian Journal of Human Genetics
- Vol. 11 (2) , 76
Detection of two rare β -thalassemia mutations [-90 (C ® T) and CD 26 (C ®T)] among Indians
BACKGROUND : β -Thalassemia (β -thal) is present in practically every caste group in Indians. Molecular characterization of β -thal in these groups has revealed an extremely heterogeneous picture. AIM : To identify all the mutations and to detect the novel mutations using a versatile mutation detection technique. MATERIALS AND METHODS : Denaturing gradient gel electrophoresis (DGGE) has been established to scan the entire β -globin gene to localize the mutation followed by DNA sequencing for characterization. The DNA samples from two families referred to us either for prenatal diagnosis or for DNA studies were studied. RESULTS : Atypical DGGE patterns in fragments B & A indicating the presence of the mutation, have been detected in both the families. DNA sequencing revealed two rare patterns fragments with patterns in fragments β -thal mutations [CD 26 (C
- 1 January 2005
- Published by CLOCKSS Archive in Indian Journal of Human Genetics
- Vol. 11 (2) , 76
Open AccessDetection of two rare β -thalassemia mutations [-90 (C ® T) and CD 26 (C ®T)] among Indians
BACKGROUND : β -Thalassemia (β -thal) is present in practically every caste group in Indians. Molecular characterization of β -thal in these groups has revealed an extremely heterogeneous picture. AIM : To identify all the mutations and to detect the novel mutations using a versatile mutation detection technique. MATERIALS AND METHODS : Denaturing gradient gel electrophoresis (DGGE) has been established to scan the entire β -globin gene to localize the mutation followed by DNA sequencing for characterization. The DNA samples from two families referred to us either for prenatal diagnosis or for DNA studies were studied. RESULTS : Atypical DGGE patterns in fragments B & A indicating the presence of the mutation, have been detected in both the families. DNA sequencing revealed two rare patterns fragments with patterns in fragments β -thal mutations [CD 26 (C
- 1 December 2004
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 26 (6) , 419-422
An interplay of alleviating mutations in the clinical phenotype of beta-thalassaemia intermedia
Prediction of a beta-thalassaemia major phenotype from the beta-genotype is generally relatively straightforward. However, despite the ability to accurately define the beta-thalassaemia mutations, prediction of a beta-thalassaemia intermedia phenotype from the genotype sometimes remains problematic and this has important implications in genetic counselling and prenatal diagnosis. We report a 11-year-old Indian male child with a thalassaemia intermedia phenotype. beta-Globin gene analysis of the family showed that he was a compound heterozygote with the -88 (C-->T) beta+-mutation and the IVS1 nt 130 (G-->C) beta0-mutation. Both these mutations are rare among Indians. The propositus was also found to be heterozygous for the XmnI polymorphism and had a normal alpha-genotype. In this family interplay of two alleviating mutations (a milder promoter mutation along with a gene for raised HbF) might have synergistically compensated for lack of globin chains in the patient. Hence, the nature of the beta-genotype as well as the knowledge of the presence or absence of alleviating factors will help the clinician to decide whether early commencement of a regular transfusion regime is necessary.
- 1 December 2004
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 26 (6) , 419-422
An interplay of alleviating mutations in the clinical phenotype of beta-thalassaemia intermedia
Prediction of a beta-thalassaemia major phenotype from the beta-genotype is generally relatively straightforward. However, despite the ability to accurately define the beta-thalassaemia mutations, prediction of a beta-thalassaemia intermedia phenotype from the genotype sometimes remains problematic and this has important implications in genetic counselling and prenatal diagnosis. We report a 11-year-old Indian male child with a thalassaemia intermedia phenotype. beta-Globin gene analysis of the family showed that he was a compound heterozygote with the -88 (C-->T) beta+-mutation and the IVS1 nt 130 (G-->C) beta0-mutation. Both these mutations are rare among Indians. The propositus was also found to be heterozygous for the XmnI polymorphism and had a normal alpha-genotype. In this family interplay of two alleviating mutations (a milder promoter mutation along with a gene for raised HbF) might have synergistically compensated for lack of globin chains in the patient. Hence, the nature of the beta-genotype as well as the knowledge of the presence or absence of alleviating factors will help the clinician to decide whether early commencement of a regular transfusion regime is necessary.
- 1 September 2004
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 33 (2) , 153-157
Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India
- 1 September 2004
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 33 (2) , 153-157
Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India
- 30 June 2003
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 30 (3) , 246-247
Molecular characterization of G6PD Insuli—a novel 989 CGC → CAC (330 Arg → His) mutation in the Indian population
- 30 June 2003
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 30 (3) , 246-247
Molecular characterization of G6PD Insuli—a novel 989 CGC → CAC (330 Arg → His) mutation in the Indian population
- 28 January 2003
- Published by Wiley in American Journal of Hematology
- Vol. 72 (2) , 150-151
G6PD deficiency and malaria in India
- 28 January 2003
- Published by Wiley in American Journal of Hematology
- Vol. 72 (2) , 150-151
G6PD deficiency and malaria in India